Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.


OBJECTIVE To assess the results of retroperitoneal lymph node dissection (RPLND) of residual masses in patients with disseminated non-seminomatous germ cell tumour treated with cisplatin-based chemotherapy, both in terms of extension of surgery, morbidity and survival. PATIENTS AND METHODS Retrospectively, all patients treated for non-seminomatous germ… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics